EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H33NO3 |
| Net Charge | 0 |
| Average Mass | 395.543 |
| Monoisotopic Mass | 395.24604 |
| SMILES | CC(C)=CCC/C(C)=C/CC/C(C)=C/CC1(O)C(=O)C(C)=[N+]([O-])c2ccccc21 |
| InChI | InChI=1S/C25H33NO3/c1-18(2)10-8-11-19(3)12-9-13-20(4)16-17-25(28)22-14-6-7-15-23(22)26(29)21(5)24(25)27/h6-7,10,12,14-16,28H,8-9,11,13,17H2,1-5H3/b19-12+,20-16+ |
| InChIKey | RNXNMMDMLFJCKP-YEFHWUCQSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Stigmatella aurantiaca Sg a15 (ncbitaxon:675526) | - | PubMed (22907798) | Strain: Sg a15 |
| Roles Classification |
|---|
| Biological Role: | bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 4-hydroxy-2-methyl-3-oxo-[(2E,6E)-farnesyl]-3,4-dihydroquinoline-1-oxide (CHEBI:90785) has role bacterial metabolite (CHEBI:76969) |
| 4-hydroxy-2-methyl-3-oxo-[(2E,6E)-farnesyl]-3,4-dihydroquinoline-1-oxide (CHEBI:90785) is a cyclic ketone (CHEBI:3992) |
| 4-hydroxy-2-methyl-3-oxo-[(2E,6E)-farnesyl]-3,4-dihydroquinoline-1-oxide (CHEBI:90785) is a olefinic compound (CHEBI:78840) |
| 4-hydroxy-2-methyl-3-oxo-[(2E,6E)-farnesyl]-3,4-dihydroquinoline-1-oxide (CHEBI:90785) is a quinoline N-oxide (CHEBI:26508) |
| 4-hydroxy-2-methyl-3-oxo-[(2E,6E)-farnesyl]-3,4-dihydroquinoline-1-oxide (CHEBI:90785) is a tertiary alcohol (CHEBI:26878) |
| 4-hydroxy-2-methyl-3-oxo-[(2E,6E)-farnesyl]-3,4-dihydroquinoline-1-oxide (CHEBI:90785) is a tertiary α-hydroxy ketone (CHEBI:139592) |
| IUPAC Name |
|---|
| 4-hydroxy-2-methyl-1-oxo-4-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-1λ5-quinolin-3(4H)-one |
| Synonym | Source |
|---|---|
| 4-hydroxy-2-methyl-3-oxo-4-farnesyl-3,4-dihydroquinoline-1-oxide | MetaCyc |
| UniProt Name | Source |
|---|---|
| 4-hydroxy-2-methyl-3-oxo-4-[(2E,6E)-farnesyl]-3,4-dihydroquinoline 1-oxide | UniProt |
| Manual Xrefs | Databases |
|---|---|
| CPD-18733 | MetaCyc |
| Citations |
|---|